Market Overview

Pluristem Announces $3.3M Grant by Israeli Government


Pluristem Therapeutics Inc. (Nasdaq: PSTI) today announced that its wholly owned subsidiary, Pluristem Ltd., has been awarded 12.7 million New Israeli Shekels (approximately $3.3 million) from the Israel Innovation Authority (Previously the Office of the Chief Scientist ‘OCS') of the Israeli Ministry of Economy & Industry. The grant will support Clinical trials and R&D activities for calendar year 2016.

"We are delighted to receive the Israeli Innovation Authority Grant this year," stated Zami Aberman, Chairman and CEO. "The continued backing of the Israeli Innovation Authority is a vote of confidence in Pluristem technology and strategy and support the execution of our plans."

Posted-In: News


Related Articles (PSTI)

View Comments and Join the Discussion!

Partner Center